C
Chuan Chuan C Wun
Researcher at University of Texas Health Science Center at Houston
Publications - 6
Citations - 8122
Chuan Chuan C Wun is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Internal medicine & Myocardial infarction. The author has an hindex of 3, co-authored 3 publications receiving 8013 citations. Previous affiliations of Chuan Chuan C Wun include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks,Marc A. Pfeffer,Lemuel A. Moyé,Jean L. Rouleau,John D. Rutherford,Thomas G. Cole,Lisa E. Brown,J. W. Warnica,J. M. O. Arnold,Chuan Chuan C Wun,Barry R. Davis,Eugene Braunwald +11 more
TL;DR: It is demonstrated that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels and was also greater in patients with higher pretreatment levels of LDL cholesterol.
Journal ArticleDOI
Ventricular dysfunction and the risk of stroke after myocardial infarction
Evan Loh,Martin St. John Sutton,Chuan Chuan C Wun,Jean L. Rouleau,Greg C. Flaker,Stephen S. Gottlieb,Gervasio A. Lamas,Lemuel A. Moyé,Samuel Z. Goldhaber,Marc A. Pfeffer +9 more
TL;DR: During the five years after myocardial infarction, patients have a substantial risk of stroke and a decreased ejection fraction and older age are both independent predictors of an increased risk of Stroke.
Journal ArticleDOI
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction : effect of captopril
Jean L. Rouleau,Milton Packer,Lemuel A. Moyé,Jacques de Champlain,Daniel G. Bichet,Marc Klein,Jacques R. Rouleau,Bruce Sussex,J. Malcolm O. Arnold,Francois Sestier,John O. Parker,Patricia McEwan,Victoria Bernstein,T. Edward Cuddy,Gervasio A. Lamas,Stephen S. Gottlieb,John McCans,Claude Nadeau,François Delage,Chuan Chuan C Wun,Marc A. Pfeffer +20 more
TL;DR: Only plasma renin activity and aldosterone, atrial natriuretic peptide and arginine vasopressin were independent predictors of the combined end points of cardiovascular mortality, development of severe heart failure or recurrent myocardial infarction.
Journal ArticleDOI
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia
Wojciech Jurczak,N Elmusharaf,Christopher P. Fox,William Townsend,Amanda G. Paulovich,Jeffrey R. Whiteaker,Fanny Krantz,Chuan Chuan C Wun,Graeme Parr,Shri Niwas Sharma,Veerendra Munugalavadla,Richa Manwani,Emma Dean,Talha Munir +13 more
TL;DR: Ceralasertib, a selective ataxia telangiectasia (ATR) inhibitor, demonstrated synergistic preclinical activity with a Bruton tyrosine kinase (BTK) inhibitor in TP53-and ATM-defective CLL cells as discussed by the authors .
Journal ArticleDOI
Safety and efficacy of ABR in pts with TN or R/R MCL: Ph Ib trial.
Tycel Phillips,Michael Wang,Tadeusz Robak,David Gallinson,Don A. Stevens,Krish Patel,Safaa A Ramadan,Chuan Chuan C Wun,Wojciech Jurczak,Stephen D. Smith +9 more
TL;DR: In this article , the authors presented updated data on safety and efficacy of ABR in patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL).